United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 - 2023

1. Executive Summary

2. Market Size & Analysis: United States Non–Invasive Prenatal Testing (2015 – 2023)

• 2.1 Overall Actual NIPT Test Volume & Forecast (2015 - 2023)
  • 2.1.1 Average Risk Actual NIPT Test Volume
  • 2.1.2 High Risk Actual NIPT Test Volume
• 2.2 Overall Actual NIPT Test Market Revenue & Forecast (2015 - 2023)
  • 2.2.1 Average Risk Actual NIPT Test Market Revenue
  • 2.2.2 High Risk Actual NIPT Test Market Revenue

3. Market Opportunity Assessment: United States Non–Invasive Prenatal Testing (2015 – 2023)

• 3.1 Overall Potential NIPT Test Volume & Forecast (2015 - 2023)
  • 3.1.1 Average Risk Potential NIPT Test Volume
  • 3.1.2 High Risk Potential NIPT Test Volume
• 3.2 Overall Potential NIPT Test Market Revenue & Forecast (2015 - 2023)
  • 3.2.1 Average Risk Potential NIPT Test Market Revenue
  • 3.2.2 High Risk Potential NIPT Test Market Revenue

4. Key Drivers and Inhibitors of the United States NIPT Test Market

• 4.1 Market Drivers
• 4.2 Inhibitors

5. Non–Invasive Prenatal Testing Competitive Analysis: By Company

6. United States NIPT Test Market: Reimbursement & Regulation System

• 6.1 Reimbursement System
• 6.2 Regulation System

7. Major Deals in Non–Invasive Prenatal Testing Market

• 7.1 Collaboration Deals
• 7.2 Venture Capital Investment
• 7.3 Merger and Acquisition
• 7.4 Exclusive Agreement
• 7.5 Licensing Agreement
• 7.6 Distribution Agreement
• 7.7 Partnership Deals

8. Non–Invasive Prenatal Testing Implementation – High–Income Countries

• 8.1.1 Clinical Issues
• 8.1.2 Ethical Issues
• 8.1.3 Legal and Regulatory Issues

9. Key Companies Analysis

• 9.1 Sequenom Laboratories (LabCorp)
  • 9.1.1 Business Overview
  • 9.1.2 NIPT Test Portfolio
  • 9.1.3 NIPT Test Analysis (Volume and Value)
    • 9.1.3.1 Overall NIPT Test Volume & Forecast
    • 9.1.3.2 Overall NIPT Test Market Revenue & Forecast
  • 9.1.4 Sequenom Laboratories – International Distributors
  • 9.1.5 NIPT Test - Latest Development & Trends
• 9.2 Ariosa Diagnostics (Roche)
  • 9.2.1 Business Overview
  • 9.2.2 NIPT Test Portfolio
  • 9.2.3 NIPT Test Analysis (Volume and Value)
    • 9.2.3.1 Overall NIPT Test Volume & Forecast
    • 9.2.3.2 Overall NIPT Test Market Revenue & Forecast
  • 9.2.4 NIPT Test - Latest Development & Trends
• 9.3 Illumina
  • 9.3.1 Business Overview
  • 9.3.2 NIPT Test Portfolio
  • 9.3.3 NIPT Test Analysis (Volume and Value)
    • 9.3.3.1 Overall NIPT Test Volume & Forecast
    • 9.3.3.2 Overall NIPT Test Market Revenue & Forecast
  • 9.3.4 NIPT Test - Latest Development & Trends
• 9.4 Natera
  • 9.4.1 Business Overview
  • 9.4.2 NIPT Test Portfolio
  • 9.4.3 NIPT Test Analysis (Volume and Value)
    • 9.4.3.1 Overall NIPT Test Volume & Forecast
    • 9.4.3.2 Overall NIPT Test Market Revenue & Forecast
  • 9.4.4 NIPT Test - Latest Development & Trends
• 9.5 Quest Diagnostics
  • 9.5.1 Business Overview
  • 9.5.2 NIPT Test Portfolio
  • 9.5.3 NIPT Test - Latest Development & Trends

List of Tables

Table 3 1: Maternal Age at Delivery and Risk of Down Syndrome

Table 6 1: Non–Invasive Prenatal Testing – Comparative Tests Analysis

Table 4 1: NIPT Test CMS Price(US$),2017

Table 6 2: Non–Invasive Prenatal Testing – Collaboration Deals, 2007 – 2018

Table 6 3: Non–Invasive Prenatal Testing – Venture Capital Investment, 2011 – 2015

Table 6 4: Non–Invasive Prenatal Testing – Merger & Acquisition, 2013 – 2016

Table 6 5: Non–Invasive Prenatal Testing – Exclusive Agreement, 2008 – 2016

Table 6 6: Non–Invasive Prenatal Testing – Licensing Agreement, 2007 – 2015

Table 6 7: Non–Invasive Prenatal Testing – Distribution Agreement, 2012 – 2014

Table 6 8: Non–Invasive Prenatal Testing – Partnership Deals, 2013 – 2015

List of Figures

Figure 2 1: United States – Actual NIPT Test Volume(Thousand),2015 – 2017

Figure 2 2: United States – Forecast for Actual NIPT Test Volume(Thousand),2018 – 2023

Figure 2 3: United States – Average Risk Actual NIPT Test Volume(Thousand),2015 – 2017

Figure 2 4: United States – Forecast for Average Risk Actual NIPT Test Volume(Thousand),2018 – 2023

Figure 2 5: United States – High Risk Actual NIPT Test Volume(Thousand),2015 – 2017

Figure 2 6: United States – Forecast for High Risk Actual NIPT Test Volume(Thousand),2018 – 2023

Figure 2 13: United States – Actual NIPT Test Market Revenue (Million US$),2015 – 2017

Figure 2 14: United States – Forecast for Actual NIPT Test Market Revenue (Million US$),2018 – 2023

Figure 2 15: United States – Average Risk Actual NIPT Test Market Revenue (Million US$),2015 – 2017

Figure 2 16: United States – Forecast for Average Risk Actual NIPT Test Market Revenue (Million US$),2018 – 2023

Figure 2 17: United States – High Risk Actual NIPT Test Market Revenue (Million US$),2015 – 2017

Figure 2 18: United States – Forecast for High Risk Actual NIPT Test Market Revenue (Million US$),2018 – 2023

Figure 2 7: United States – Potential NIPT Test Volume(Thousand),2015 – 2017

Figure 2 8: United States – Forecast for Potential NIPT Test Volume(Thousand),2018 – 2023

Figure 2 9: United States – Average Risk Potential NIPT Test Volume(Thousand),2015 – 2017

Figure 2 10: United States – Forecast for Average Risk Potential NIPT Test Volume(Thousand),2018 – 2023

Figure 2 11: United States – High Risk Potential NIPT Test Volume(Thousand),2015 – 2017

Figure 2 12: United States – Forecast for High Risk Potential NIPT Test Volume(Thousand),2018 – 2023

Figure 2 19: United States – Potential NIPT Test Market Revenue (Million US$),2015 – 2017

Figure 2 20: United States – Forecast for Potential NIPT Test Market Revenue (Million US$),2018 – 2023

Figure 2 21: United States – Average Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2017

Figure 2 22: United States – Forecast for Average Risk Potential NIPT Test Market Revenue (Million US$),2018 – 2023

Figure 2 23: United States – High Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2017

Figure 2 24: United States – Forecast for High Risk Potential NIPT Test Market Revenue (Million US$),2018 – 2023

Figure 7 1: Sequenom – Overall NIPT Test Volume (Thousand), 2011 – 2017

Figure 7 2: Sequenom – Forecast for Overall NIPT Test Volume (Thousand), 2018 – 2023

Figure 7 3: Sequenom - Overall NIPT Test Market Revenue (Million US$),2011 – 2016

Figure 7 4: Sequenom – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023

Figure 7 5: Ariosa Diagnostics – Overall NIPT Test Volume (Thousand), 2012 – 2017

Figure 7 6: Ariosa Diagnostics – Forecast for Overall NIPT Test Volume (Thousand), 2018 – 2023

Figure 7 7: Ariosa Diagnostics - Overall NIPT Test Market Revenue (Million US$),2012 – 2017

Figure 7 8: Ariosa Diagnostics – Forecast for Overall NIPT Test Market Revenue (Million US$),2018 – 2023

Figure 7 9: Illumina – Overall NIPT Test Volume (Thousand), 2012 – 2017

Figure 7 10: Illumina – Forecast for Overall NIPT Test Volume (Thousand), 2018 – 2023

Figure 7 11: Illumina - Overall NIPT Test Market Revenue (Million US$),2012 – 2017

Figure 7 12: Illumina – Forecast for Overall NIPT Test Market Revenue (Million US$),2018 – 2023

Figure 7 13: Natera – Overall NIPT Test Volume (Thousand), 2013 – 2017

Figure 7 14: Natera – Forecast for Overall NIPT Test Volume (Thousand), 2018 – 2023

Figure 7 15: Natera - Overall NIPT Test Market Revenue (Million US$),2013 – 2017

Figure 7 16: Natera – Forecast for Overall NIPT Test Market Revenue (Million US$),2018 – 2023